BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 24899645)

  • 1. Seizure prognosis in brain tumors: new insights and evidence-based management.
    Vecht CJ; Kerkhof M; Duran-Pena A
    Oncologist; 2014 Jul; 19(7):751-9. PubMed ID: 24899645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
    Vecht C; Royer-Perron L; Houillier C; Huberfeld G
    Curr Pharm Des; 2017; 23(42):6464-6487. PubMed ID: 29076421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing antiepileptic drug treatment in tumoral epilepsy.
    Perucca E
    Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
    van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
    J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of epilepsy in brain tumor patients.
    van der Meer PB; Taphoorn MJB; Koekkoek JAF
    Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors.
    Newton HB; Wojkowski J
    Curr Treat Options Oncol; 2024 Mar; 25(3):389-403. PubMed ID: 38353859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma.
    Koekkoek JA; Dirven L; Taphoorn MJ
    Expert Rev Neurother; 2017 Feb; 17(2):193-202. PubMed ID: 27484737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure characteristics and prognostic factors of gliomas.
    Kerkhof M; Vecht CJ
    Epilepsia; 2013 Dec; 54 Suppl 9():12-7. PubMed ID: 24328866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug prophylaxis in primary brain tumor patients: is current practice in agreement to the consensus?
    de Oliveira JA; Santana IA; Caires IQ; Caires-Lima R; Miranda VC; Protásio BM; Rocha LS; Braga HF; Mencarini AM; Teixeira MJ; Castro LH; Feher O
    J Neurooncol; 2014 Nov; 120(2):399-403. PubMed ID: 25085213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.
    Rudà R; Bello L; Duffau H; Soffietti R
    Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv55-64. PubMed ID: 23095831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of brain tumor-related epilepsy.
    Klinger NV; Shah AK; Mittal S
    Neurol India; 2017; 65(Supplement):S60-S70. PubMed ID: 28281497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy in the end-of-life phase in patients with high-grade gliomas.
    Pace A; Villani V; Di Lorenzo C; Guariglia L; Maschio M; Pompili A; Carapella CM
    J Neurooncol; 2013 Jan; 111(1):83-6. PubMed ID: 23086435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
    van Opijnen MP; van der Meer PB; Dirven L; Fiocco M; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
    J Neurooncol; 2021 Aug; 154(1):73-81. PubMed ID: 34196916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures in oligodendroglial tumors.
    Kerkhof M; Benit C; Duran-Pena A; Vecht CJ
    CNS Oncol; 2015; 4(5):347-56. PubMed ID: 26478444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
    Asano K; Hasegawa S; Matsuzaka M; Ohkuma H
    J Neurosurg; 2022 Jan; 136(1):76-87. PubMed ID: 34271546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
    Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
    Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations.
    Mercadé Cerdá JM; López Gonzalez FJ; Serrano Castro P; Castro Vilanova MD; Campos Blanco DM; Querol Pascual MR;
    Neurologia (Engl Ed); 2020 Mar; 35(2):115-125. PubMed ID: 29530436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.